Skip to main content
. 2020 Jun 22;9(6):1523. doi: 10.3390/cells9061523

Table 2.

Patients’ characteristics according to SPARC methylation status (methylated/unmethylated).

Characteristics SPARC Unmethylated SPARC Methylated p-Value *
n 23 36
Age at Diagnosis (mean yy ± SD) 67.5 ± 8.7 67.8 ± 8.3 0.704
Gender (n, %) 0.726
Male 19 (82.6) 31 (86.1)
Female 4 (17.4) 5 (13.9)
Smoking Status (n, %) 0.741
Smoker 10 (43.5) 18 (50.0)
Never smoker 3 (13.0) 3 (8.3)
Former smoker 10 (43.5) 15 (41.7)
Disease Stage 0.936
IA/B 11 (47.8) 17 (47.2)
IIA/B 5 (21.7) 9 (25.0)
IIIA/B 4 (17.4) 7 (19.5)
IV 3 (13.1) 3 (8.3)
pT § (n, %) 0.604
T1 7 (30.4) 13 (36.1)
T2 12 (52.2) 15 (41.7)
T3 1 (4.4) 5 (13.9)
T4 3 (13.0) 3 (8.3)
pN (n, %) 0.701
N0 16 (69.6) 26 (72.2)
N1 5 (21.7) 5 (13.9)
N2 2 (8.7) 5 (13.9)
pM (n, %) 0.369
M0 20 (87.0) 34 (94.4)
M1 3 (13.0) 2 (5.6)
Histology 0.423
ADC 15 (65.2) 19 (52.8)
SqCC 8 (34.8) 17 (47.2)
KRAS Status § 1.000
Wild-type 18 (90.0) 29 (90.6)
Mutated 2 (10.0) 3 (9.4)
Missing data 3 4

ADC, adenocarcinoma; SqCC, squamous cell carcinoma; yy, years; SD, standard deviation. * p-values from Mann-Whitney U test or Fisher exact test for continuous and categorical variables, respectively; § patients with missing values were not considered.